Frontiers in Public Health-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1209895, encodeId=944f12098952a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2022-2-9 投稿 2022-3-4 两个审稿人，均为大修；交互界面打开 2022-3-24 两个审稿人，endorsed 2033-3-31 accepted 为了毕业投的，还好，审稿时间较快，目前接收的最快的一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=710a2027187, createdName=小木公, createdTime=Sat Apr 09 21:31:25 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003160, encodeId=c1c410031608f, content=26 Jul 2021 Article accepted for publication. Review of Review Editor 2 finalized. Corresponding Author re-submitted manuscript. 15 Jul 2021 Review of Review Editor 1 finalized. 14 Jul 2021 Corresponding Author re-submitted manuscript. 08 Jul 2021 Interactive review forum activated. 07 Jun 2021 Corresponding Author submitted manuscript. 2个大修版面费贵 <a href='/topic/show?id=14d4259120b' target=_blank style='color:#2F92EE;'>#传染病#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=10, topicName=null, topicId=null, topicList=[TopicDto(id=25912, encryptionId=14d4259120b, topicName=传染病)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Tue Jul 27 22:51:33 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1215262, encodeId=889912152622b, content=21提交，22号要求提供原始数据，22晚上提交原始数据，至今快一周了，初步审查还没结束，各位initial validation多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=Uro_Hu, createdTime=Thu Apr 28 10:50:21 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223998, encodeId=1ad012239984e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康;糖尿病 经验分享：3.24 投稿 5.11 独立审稿开始 5.17 审稿报告1提交,微修 5.23 审稿报告2提交，微修 5.26 交叉评审激活 5.27 返修 5.31 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210819/e4601e63935540b094f6dcf2255c699c/bf4f523e8d894500a5e99cc898b63e92.jpg, createdBy=b7fb5436174, createdName=ms5000001545848377, createdTime=Thu Jun 02 09:58:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220564, encodeId=031512205643b, content=审稿速度:1.0 偏重的研究方向：近视;心理 经验分享：本人第一次写SCI，4月22日投稿，5.17第一个审稿人意见修回，改语法和图表格式，其他没意见，开心，期待下一个审稿人建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85145130725, createdName=146561f5m66暂无昵称, createdTime=Tue May 17 23:03:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181761, encodeId=da511181e6185, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2950.0 偏重的研究方向：公共卫生;糖尿病 经验分享：2021年11月底投稿，编辑很快就处理了，并让我邮件他推荐审稿人，我就随便巴拉了几个不认识的审稿人，12月中旬返回一个审稿意见是小修并且直接同意发表，就关了互动模块了，12月23号又返回了一个修稿意见认为应该换一个统计方法，两天就返回去修稿意见了，12月底就接受了，1月初交了版面费。目前在等待清样了。这是我目前为止周期最快的一篇文章了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61f02159025, createdName=abbyabbyabby, createdTime=Fri Jan 07 09:56:22 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053521, encodeId=5b0f1053521db, content=糟糕透顶别投快跑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d055501799, createdName=ms6000000301719206, createdTime=Tue Sep 21 16:19:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1084036, encodeId=b3d61084036c2, content=杂志还算比较友好，但是发文速度非常慢，3月份投稿，一直找不到审稿人，期间推荐了三次审稿人，都没得消息，最后4个月才找到审稿人，又是漫长的等待。最后还好接受了，真的太漫长，前后加起来差不多10个月。着急毕业的建议不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lZCviaxzMSO1NPueY33sTwrlpzHGaNcwl2E5eYcDkPk97AfflLVSNZ8aFkXLBqRUT7QxFRQXRZKSlSctwT0eBrg/132, createdBy=82565232753, createdName=kk个, createdTime=Fri Dec 24 21:20:26 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2022-04-09 小木公

审稿速度:2.0 | 投稿命中率:50.0
经验分享：2022-2-9 投稿
2022-3-4 两个审稿人，均为大修；交互界面打开
2022-3-24 两个审稿人，endorsed
2033-3-31 accepted
为了毕业投的，还好，审稿时间较快，目前接收的最快的一篇

86 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209895, encodeId=944f12098952a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2022-2-9 投稿 2022-3-4 两个审稿人，均为大修；交互界面打开 2022-3-24 两个审稿人，endorsed 2033-3-31 accepted 为了毕业投的，还好，审稿时间较快，目前接收的最快的一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=710a2027187, createdName=小木公, createdTime=Sat Apr 09 21:31:25 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003160, encodeId=c1c410031608f, content=26 Jul 2021 Article accepted for publication. Review of Review Editor 2 finalized. Corresponding Author re-submitted manuscript. 15 Jul 2021 Review of Review Editor 1 finalized. 14 Jul 2021 Corresponding Author re-submitted manuscript. 08 Jul 2021 Interactive review forum activated. 07 Jun 2021 Corresponding Author submitted manuscript. 2个大修版面费贵 <a href='/topic/show?id=14d4259120b' target=_blank style='color:#2F92EE;'>#传染病#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=10, topicName=null, topicId=null, topicList=[TopicDto(id=25912, encryptionId=14d4259120b, topicName=传染病)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Tue Jul 27 22:51:33 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1215262, encodeId=889912152622b, content=21提交，22号要求提供原始数据，22晚上提交原始数据，至今快一周了，初步审查还没结束，各位initial validation多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=Uro_Hu, createdTime=Thu Apr 28 10:50:21 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223998, encodeId=1ad012239984e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康;糖尿病 经验分享：3.24 投稿 5.11 独立审稿开始 5.17 审稿报告1提交,微修 5.23 审稿报告2提交，微修 5.26 交叉评审激活 5.27 返修 5.31 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210819/e4601e63935540b094f6dcf2255c699c/bf4f523e8d894500a5e99cc898b63e92.jpg, createdBy=b7fb5436174, createdName=ms5000001545848377, createdTime=Thu Jun 02 09:58:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220564, encodeId=031512205643b, content=审稿速度:1.0 偏重的研究方向：近视;心理 经验分享：本人第一次写SCI，4月22日投稿，5.17第一个审稿人意见修回，改语法和图表格式，其他没意见，开心，期待下一个审稿人建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85145130725, createdName=146561f5m66暂无昵称, createdTime=Tue May 17 23:03:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181761, encodeId=da511181e6185, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2950.0 偏重的研究方向：公共卫生;糖尿病 经验分享：2021年11月底投稿，编辑很快就处理了，并让我邮件他推荐审稿人，我就随便巴拉了几个不认识的审稿人，12月中旬返回一个审稿意见是小修并且直接同意发表，就关了互动模块了，12月23号又返回了一个修稿意见认为应该换一个统计方法，两天就返回去修稿意见了，12月底就接受了，1月初交了版面费。目前在等待清样了。这是我目前为止周期最快的一篇文章了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61f02159025, createdName=abbyabbyabby, createdTime=Fri Jan 07 09:56:22 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053521, encodeId=5b0f1053521db, content=糟糕透顶别投快跑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d055501799, createdName=ms6000000301719206, createdTime=Tue Sep 21 16:19:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1084036, encodeId=b3d61084036c2, content=杂志还算比较友好，但是发文速度非常慢，3月份投稿，一直找不到审稿人，期间推荐了三次审稿人，都没得消息，最后4个月才找到审稿人，又是漫长的等待。最后还好接受了，真的太漫长，前后加起来差不多10个月。着急毕业的建议不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lZCviaxzMSO1NPueY33sTwrlpzHGaNcwl2E5eYcDkPk97AfflLVSNZ8aFkXLBqRUT7QxFRQXRZKSlSctwT0eBrg/132, createdBy=82565232753, createdName=kk个, createdTime=Fri Dec 24 21:20:26 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2021-07-27 爱爬树的松鼠

26 Jul 2021 Article accepted for publication. Review of Review Editor 2 finalized. Corresponding Author re-submitted manuscript. 15 Jul 2021 Review of Review Editor 1 finalized. 14 Jul 2021 Corresponding Author re-submitted manuscript. 08 Jul 2021 Interactive review forum activated. 07 Jun 2021 Corresponding Author submitted manuscript. 2个大修版面费贵 #传染病#

105 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209895, encodeId=944f12098952a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2022-2-9 投稿 2022-3-4 两个审稿人，均为大修；交互界面打开 2022-3-24 两个审稿人，endorsed 2033-3-31 accepted 为了毕业投的，还好，审稿时间较快，目前接收的最快的一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=710a2027187, createdName=小木公, createdTime=Sat Apr 09 21:31:25 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003160, encodeId=c1c410031608f, content=26 Jul 2021 Article accepted for publication. Review of Review Editor 2 finalized. Corresponding Author re-submitted manuscript. 15 Jul 2021 Review of Review Editor 1 finalized. 14 Jul 2021 Corresponding Author re-submitted manuscript. 08 Jul 2021 Interactive review forum activated. 07 Jun 2021 Corresponding Author submitted manuscript. 2个大修版面费贵 <a href='/topic/show?id=14d4259120b' target=_blank style='color:#2F92EE;'>#传染病#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=10, topicName=null, topicId=null, topicList=[TopicDto(id=25912, encryptionId=14d4259120b, topicName=传染病)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Tue Jul 27 22:51:33 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1215262, encodeId=889912152622b, content=21提交，22号要求提供原始数据，22晚上提交原始数据，至今快一周了，初步审查还没结束，各位initial validation多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=Uro_Hu, createdTime=Thu Apr 28 10:50:21 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223998, encodeId=1ad012239984e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康;糖尿病 经验分享：3.24 投稿 5.11 独立审稿开始 5.17 审稿报告1提交,微修 5.23 审稿报告2提交，微修 5.26 交叉评审激活 5.27 返修 5.31 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210819/e4601e63935540b094f6dcf2255c699c/bf4f523e8d894500a5e99cc898b63e92.jpg, createdBy=b7fb5436174, createdName=ms5000001545848377, createdTime=Thu Jun 02 09:58:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220564, encodeId=031512205643b, content=审稿速度:1.0 偏重的研究方向：近视;心理 经验分享：本人第一次写SCI，4月22日投稿，5.17第一个审稿人意见修回，改语法和图表格式，其他没意见，开心，期待下一个审稿人建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85145130725, createdName=146561f5m66暂无昵称, createdTime=Tue May 17 23:03:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181761, encodeId=da511181e6185, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2950.0 偏重的研究方向：公共卫生;糖尿病 经验分享：2021年11月底投稿，编辑很快就处理了，并让我邮件他推荐审稿人，我就随便巴拉了几个不认识的审稿人，12月中旬返回一个审稿意见是小修并且直接同意发表，就关了互动模块了，12月23号又返回了一个修稿意见认为应该换一个统计方法，两天就返回去修稿意见了，12月底就接受了，1月初交了版面费。目前在等待清样了。这是我目前为止周期最快的一篇文章了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61f02159025, createdName=abbyabbyabby, createdTime=Fri Jan 07 09:56:22 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053521, encodeId=5b0f1053521db, content=糟糕透顶别投快跑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d055501799, createdName=ms6000000301719206, createdTime=Tue Sep 21 16:19:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1084036, encodeId=b3d61084036c2, content=杂志还算比较友好，但是发文速度非常慢，3月份投稿，一直找不到审稿人，期间推荐了三次审稿人，都没得消息，最后4个月才找到审稿人，又是漫长的等待。最后还好接受了，真的太漫长，前后加起来差不多10个月。着急毕业的建议不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lZCviaxzMSO1NPueY33sTwrlpzHGaNcwl2E5eYcDkPk97AfflLVSNZ8aFkXLBqRUT7QxFRQXRZKSlSctwT0eBrg/132, createdBy=82565232753, createdName=kk个, createdTime=Fri Dec 24 21:20:26 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2023-09-04 膨胀的指挥官来自安徽省

偏重的研究方向：高血压;公共卫生
经验分享：8月26日投完，今天看了下在第三步分配编辑

59 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209895, encodeId=944f12098952a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2022-2-9 投稿 2022-3-4 两个审稿人，均为大修；交互界面打开 2022-3-24 两个审稿人，endorsed 2033-3-31 accepted 为了毕业投的，还好，审稿时间较快，目前接收的最快的一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=710a2027187, createdName=小木公, createdTime=Sat Apr 09 21:31:25 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003160, encodeId=c1c410031608f, content=26 Jul 2021 Article accepted for publication. Review of Review Editor 2 finalized. Corresponding Author re-submitted manuscript. 15 Jul 2021 Review of Review Editor 1 finalized. 14 Jul 2021 Corresponding Author re-submitted manuscript. 08 Jul 2021 Interactive review forum activated. 07 Jun 2021 Corresponding Author submitted manuscript. 2个大修版面费贵 <a href='/topic/show?id=14d4259120b' target=_blank style='color:#2F92EE;'>#传染病#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=10, topicName=null, topicId=null, topicList=[TopicDto(id=25912, encryptionId=14d4259120b, topicName=传染病)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Tue Jul 27 22:51:33 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1215262, encodeId=889912152622b, content=21提交，22号要求提供原始数据，22晚上提交原始数据，至今快一周了，初步审查还没结束，各位initial validation多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=Uro_Hu, createdTime=Thu Apr 28 10:50:21 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223998, encodeId=1ad012239984e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康;糖尿病 经验分享：3.24 投稿 5.11 独立审稿开始 5.17 审稿报告1提交,微修 5.23 审稿报告2提交，微修 5.26 交叉评审激活 5.27 返修 5.31 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210819/e4601e63935540b094f6dcf2255c699c/bf4f523e8d894500a5e99cc898b63e92.jpg, createdBy=b7fb5436174, createdName=ms5000001545848377, createdTime=Thu Jun 02 09:58:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220564, encodeId=031512205643b, content=审稿速度:1.0 偏重的研究方向：近视;心理 经验分享：本人第一次写SCI，4月22日投稿，5.17第一个审稿人意见修回，改语法和图表格式，其他没意见，开心，期待下一个审稿人建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85145130725, createdName=146561f5m66暂无昵称, createdTime=Tue May 17 23:03:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181761, encodeId=da511181e6185, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2950.0 偏重的研究方向：公共卫生;糖尿病 经验分享：2021年11月底投稿，编辑很快就处理了，并让我邮件他推荐审稿人，我就随便巴拉了几个不认识的审稿人，12月中旬返回一个审稿意见是小修并且直接同意发表，就关了互动模块了，12月23号又返回了一个修稿意见认为应该换一个统计方法，两天就返回去修稿意见了，12月底就接受了，1月初交了版面费。目前在等待清样了。这是我目前为止周期最快的一篇文章了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61f02159025, createdName=abbyabbyabby, createdTime=Fri Jan 07 09:56:22 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053521, encodeId=5b0f1053521db, content=糟糕透顶别投快跑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d055501799, createdName=ms6000000301719206, createdTime=Tue Sep 21 16:19:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1084036, encodeId=b3d61084036c2, content=杂志还算比较友好，但是发文速度非常慢，3月份投稿，一直找不到审稿人，期间推荐了三次审稿人，都没得消息，最后4个月才找到审稿人，又是漫长的等待。最后还好接受了，真的太漫长，前后加起来差不多10个月。着急毕业的建议不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lZCviaxzMSO1NPueY33sTwrlpzHGaNcwl2E5eYcDkPk97AfflLVSNZ8aFkXLBqRUT7QxFRQXRZKSlSctwT0eBrg/132, createdBy=82565232753, createdName=kk个, createdTime=Fri Dec 24 21:20:26 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2022-04-28 Uro_Hu

21提交，22号要求提供原始数据，22晚上提交原始数据，至今快一周了，初步审查还没结束，各位initial validation多长时间？

84 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209895, encodeId=944f12098952a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2022-2-9 投稿 2022-3-4 两个审稿人，均为大修；交互界面打开 2022-3-24 两个审稿人，endorsed 2033-3-31 accepted 为了毕业投的，还好，审稿时间较快，目前接收的最快的一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=710a2027187, createdName=小木公, createdTime=Sat Apr 09 21:31:25 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003160, encodeId=c1c410031608f, content=26 Jul 2021 Article accepted for publication. Review of Review Editor 2 finalized. Corresponding Author re-submitted manuscript. 15 Jul 2021 Review of Review Editor 1 finalized. 14 Jul 2021 Corresponding Author re-submitted manuscript. 08 Jul 2021 Interactive review forum activated. 07 Jun 2021 Corresponding Author submitted manuscript. 2个大修版面费贵 <a href='/topic/show?id=14d4259120b' target=_blank style='color:#2F92EE;'>#传染病#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=10, topicName=null, topicId=null, topicList=[TopicDto(id=25912, encryptionId=14d4259120b, topicName=传染病)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Tue Jul 27 22:51:33 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1215262, encodeId=889912152622b, content=21提交，22号要求提供原始数据，22晚上提交原始数据，至今快一周了，初步审查还没结束，各位initial validation多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=Uro_Hu, createdTime=Thu Apr 28 10:50:21 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223998, encodeId=1ad012239984e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康;糖尿病 经验分享：3.24 投稿 5.11 独立审稿开始 5.17 审稿报告1提交,微修 5.23 审稿报告2提交，微修 5.26 交叉评审激活 5.27 返修 5.31 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210819/e4601e63935540b094f6dcf2255c699c/bf4f523e8d894500a5e99cc898b63e92.jpg, createdBy=b7fb5436174, createdName=ms5000001545848377, createdTime=Thu Jun 02 09:58:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220564, encodeId=031512205643b, content=审稿速度:1.0 偏重的研究方向：近视;心理 经验分享：本人第一次写SCI，4月22日投稿，5.17第一个审稿人意见修回，改语法和图表格式，其他没意见，开心，期待下一个审稿人建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85145130725, createdName=146561f5m66暂无昵称, createdTime=Tue May 17 23:03:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181761, encodeId=da511181e6185, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2950.0 偏重的研究方向：公共卫生;糖尿病 经验分享：2021年11月底投稿，编辑很快就处理了，并让我邮件他推荐审稿人，我就随便巴拉了几个不认识的审稿人，12月中旬返回一个审稿意见是小修并且直接同意发表，就关了互动模块了，12月23号又返回了一个修稿意见认为应该换一个统计方法，两天就返回去修稿意见了，12月底就接受了，1月初交了版面费。目前在等待清样了。这是我目前为止周期最快的一篇文章了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61f02159025, createdName=abbyabbyabby, createdTime=Fri Jan 07 09:56:22 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053521, encodeId=5b0f1053521db, content=糟糕透顶别投快跑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d055501799, createdName=ms6000000301719206, createdTime=Tue Sep 21 16:19:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1084036, encodeId=b3d61084036c2, content=杂志还算比较友好，但是发文速度非常慢，3月份投稿，一直找不到审稿人，期间推荐了三次审稿人，都没得消息，最后4个月才找到审稿人，又是漫长的等待。最后还好接受了，真的太漫长，前后加起来差不多10个月。着急毕业的建议不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lZCviaxzMSO1NPueY33sTwrlpzHGaNcwl2E5eYcDkPk97AfflLVSNZ8aFkXLBqRUT7QxFRQXRZKSlSctwT0eBrg/132, createdBy=82565232753, createdName=kk个, createdTime=Fri Dec 24 21:20:26 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2022-06-02 ms5000001545848377

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：公共健康;糖尿病
经验分享：3.24 投稿
5.11 独立审稿开始
5.17 审稿报告1提交,微修
5.23 审稿报告2提交，微修
5.26 交叉评审激活
5.27 返修
5.31 Accepted

115 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209895, encodeId=944f12098952a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2022-2-9 投稿 2022-3-4 两个审稿人，均为大修；交互界面打开 2022-3-24 两个审稿人，endorsed 2033-3-31 accepted 为了毕业投的，还好，审稿时间较快，目前接收的最快的一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=710a2027187, createdName=小木公, createdTime=Sat Apr 09 21:31:25 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003160, encodeId=c1c410031608f, content=26 Jul 2021 Article accepted for publication. Review of Review Editor 2 finalized. Corresponding Author re-submitted manuscript. 15 Jul 2021 Review of Review Editor 1 finalized. 14 Jul 2021 Corresponding Author re-submitted manuscript. 08 Jul 2021 Interactive review forum activated. 07 Jun 2021 Corresponding Author submitted manuscript. 2个大修版面费贵 <a href='/topic/show?id=14d4259120b' target=_blank style='color:#2F92EE;'>#传染病#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=10, topicName=null, topicId=null, topicList=[TopicDto(id=25912, encryptionId=14d4259120b, topicName=传染病)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Tue Jul 27 22:51:33 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1215262, encodeId=889912152622b, content=21提交，22号要求提供原始数据，22晚上提交原始数据，至今快一周了，初步审查还没结束，各位initial validation多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=Uro_Hu, createdTime=Thu Apr 28 10:50:21 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223998, encodeId=1ad012239984e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康;糖尿病 经验分享：3.24 投稿 5.11 独立审稿开始 5.17 审稿报告1提交,微修 5.23 审稿报告2提交，微修 5.26 交叉评审激活 5.27 返修 5.31 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210819/e4601e63935540b094f6dcf2255c699c/bf4f523e8d894500a5e99cc898b63e92.jpg, createdBy=b7fb5436174, createdName=ms5000001545848377, createdTime=Thu Jun 02 09:58:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220564, encodeId=031512205643b, content=审稿速度:1.0 偏重的研究方向：近视;心理 经验分享：本人第一次写SCI，4月22日投稿，5.17第一个审稿人意见修回，改语法和图表格式，其他没意见，开心，期待下一个审稿人建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85145130725, createdName=146561f5m66暂无昵称, createdTime=Tue May 17 23:03:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181761, encodeId=da511181e6185, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2950.0 偏重的研究方向：公共卫生;糖尿病 经验分享：2021年11月底投稿，编辑很快就处理了，并让我邮件他推荐审稿人，我就随便巴拉了几个不认识的审稿人，12月中旬返回一个审稿意见是小修并且直接同意发表，就关了互动模块了，12月23号又返回了一个修稿意见认为应该换一个统计方法，两天就返回去修稿意见了，12月底就接受了，1月初交了版面费。目前在等待清样了。这是我目前为止周期最快的一篇文章了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61f02159025, createdName=abbyabbyabby, createdTime=Fri Jan 07 09:56:22 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053521, encodeId=5b0f1053521db, content=糟糕透顶别投快跑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d055501799, createdName=ms6000000301719206, createdTime=Tue Sep 21 16:19:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1084036, encodeId=b3d61084036c2, content=杂志还算比较友好，但是发文速度非常慢，3月份投稿，一直找不到审稿人，期间推荐了三次审稿人，都没得消息，最后4个月才找到审稿人，又是漫长的等待。最后还好接受了，真的太漫长，前后加起来差不多10个月。着急毕业的建议不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lZCviaxzMSO1NPueY33sTwrlpzHGaNcwl2E5eYcDkPk97AfflLVSNZ8aFkXLBqRUT7QxFRQXRZKSlSctwT0eBrg/132, createdBy=82565232753, createdName=kk个, createdTime=Fri Dec 24 21:20:26 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2022-05-17 146561f5m66暂无昵称

审稿速度:1.0
偏重的研究方向：近视;心理
经验分享：本人第一次写SCI，4月22日投稿，5.17第一个审稿人意见修回，改语法和图表格式，其他没意见，开心，期待下一个审稿人建议。

70 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209895, encodeId=944f12098952a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2022-2-9 投稿 2022-3-4 两个审稿人，均为大修；交互界面打开 2022-3-24 两个审稿人，endorsed 2033-3-31 accepted 为了毕业投的，还好，审稿时间较快，目前接收的最快的一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=710a2027187, createdName=小木公, createdTime=Sat Apr 09 21:31:25 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003160, encodeId=c1c410031608f, content=26 Jul 2021 Article accepted for publication. Review of Review Editor 2 finalized. Corresponding Author re-submitted manuscript. 15 Jul 2021 Review of Review Editor 1 finalized. 14 Jul 2021 Corresponding Author re-submitted manuscript. 08 Jul 2021 Interactive review forum activated. 07 Jun 2021 Corresponding Author submitted manuscript. 2个大修版面费贵 <a href='/topic/show?id=14d4259120b' target=_blank style='color:#2F92EE;'>#传染病#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=10, topicName=null, topicId=null, topicList=[TopicDto(id=25912, encryptionId=14d4259120b, topicName=传染病)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Tue Jul 27 22:51:33 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1215262, encodeId=889912152622b, content=21提交，22号要求提供原始数据，22晚上提交原始数据，至今快一周了，初步审查还没结束，各位initial validation多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=Uro_Hu, createdTime=Thu Apr 28 10:50:21 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223998, encodeId=1ad012239984e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康;糖尿病 经验分享：3.24 投稿 5.11 独立审稿开始 5.17 审稿报告1提交,微修 5.23 审稿报告2提交，微修 5.26 交叉评审激活 5.27 返修 5.31 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210819/e4601e63935540b094f6dcf2255c699c/bf4f523e8d894500a5e99cc898b63e92.jpg, createdBy=b7fb5436174, createdName=ms5000001545848377, createdTime=Thu Jun 02 09:58:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220564, encodeId=031512205643b, content=审稿速度:1.0 偏重的研究方向：近视;心理 经验分享：本人第一次写SCI，4月22日投稿，5.17第一个审稿人意见修回，改语法和图表格式，其他没意见，开心，期待下一个审稿人建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85145130725, createdName=146561f5m66暂无昵称, createdTime=Tue May 17 23:03:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181761, encodeId=da511181e6185, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2950.0 偏重的研究方向：公共卫生;糖尿病 经验分享：2021年11月底投稿，编辑很快就处理了，并让我邮件他推荐审稿人，我就随便巴拉了几个不认识的审稿人，12月中旬返回一个审稿意见是小修并且直接同意发表，就关了互动模块了，12月23号又返回了一个修稿意见认为应该换一个统计方法，两天就返回去修稿意见了，12月底就接受了，1月初交了版面费。目前在等待清样了。这是我目前为止周期最快的一篇文章了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61f02159025, createdName=abbyabbyabby, createdTime=Fri Jan 07 09:56:22 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053521, encodeId=5b0f1053521db, content=糟糕透顶别投快跑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d055501799, createdName=ms6000000301719206, createdTime=Tue Sep 21 16:19:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1084036, encodeId=b3d61084036c2, content=杂志还算比较友好，但是发文速度非常慢，3月份投稿，一直找不到审稿人，期间推荐了三次审稿人，都没得消息，最后4个月才找到审稿人，又是漫长的等待。最后还好接受了，真的太漫长，前后加起来差不多10个月。着急毕业的建议不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lZCviaxzMSO1NPueY33sTwrlpzHGaNcwl2E5eYcDkPk97AfflLVSNZ8aFkXLBqRUT7QxFRQXRZKSlSctwT0eBrg/132, createdBy=82565232753, createdName=kk个, createdTime=Fri Dec 24 21:20:26 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2022-01-07 abbyabbyabby

审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2950.0
偏重的研究方向：公共卫生;糖尿病
经验分享：2021年11月底投稿，编辑很快就处理了，并让我邮件他推荐审稿人，我就随便巴拉了几个不认识的审稿人，12月中旬返回一个审稿意见是小修并且直接同意发表，就关了互动模块了，12月23号又返回了一个修稿意见认为应该换一个统计方法，两天就返回去修稿意见了，12月底就接受了，1月初交了版面费。目前在等待清样了。这是我目前为止周期最快的一篇文章了。

94 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209895, encodeId=944f12098952a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2022-2-9 投稿 2022-3-4 两个审稿人，均为大修；交互界面打开 2022-3-24 两个审稿人，endorsed 2033-3-31 accepted 为了毕业投的，还好，审稿时间较快，目前接收的最快的一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=710a2027187, createdName=小木公, createdTime=Sat Apr 09 21:31:25 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003160, encodeId=c1c410031608f, content=26 Jul 2021 Article accepted for publication. Review of Review Editor 2 finalized. Corresponding Author re-submitted manuscript. 15 Jul 2021 Review of Review Editor 1 finalized. 14 Jul 2021 Corresponding Author re-submitted manuscript. 08 Jul 2021 Interactive review forum activated. 07 Jun 2021 Corresponding Author submitted manuscript. 2个大修版面费贵 <a href='/topic/show?id=14d4259120b' target=_blank style='color:#2F92EE;'>#传染病#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=10, topicName=null, topicId=null, topicList=[TopicDto(id=25912, encryptionId=14d4259120b, topicName=传染病)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Tue Jul 27 22:51:33 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1215262, encodeId=889912152622b, content=21提交，22号要求提供原始数据，22晚上提交原始数据，至今快一周了，初步审查还没结束，各位initial validation多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=Uro_Hu, createdTime=Thu Apr 28 10:50:21 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223998, encodeId=1ad012239984e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康;糖尿病 经验分享：3.24 投稿 5.11 独立审稿开始 5.17 审稿报告1提交,微修 5.23 审稿报告2提交，微修 5.26 交叉评审激活 5.27 返修 5.31 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210819/e4601e63935540b094f6dcf2255c699c/bf4f523e8d894500a5e99cc898b63e92.jpg, createdBy=b7fb5436174, createdName=ms5000001545848377, createdTime=Thu Jun 02 09:58:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220564, encodeId=031512205643b, content=审稿速度:1.0 偏重的研究方向：近视;心理 经验分享：本人第一次写SCI，4月22日投稿，5.17第一个审稿人意见修回，改语法和图表格式，其他没意见，开心，期待下一个审稿人建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85145130725, createdName=146561f5m66暂无昵称, createdTime=Tue May 17 23:03:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181761, encodeId=da511181e6185, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2950.0 偏重的研究方向：公共卫生;糖尿病 经验分享：2021年11月底投稿，编辑很快就处理了，并让我邮件他推荐审稿人，我就随便巴拉了几个不认识的审稿人，12月中旬返回一个审稿意见是小修并且直接同意发表，就关了互动模块了，12月23号又返回了一个修稿意见认为应该换一个统计方法，两天就返回去修稿意见了，12月底就接受了，1月初交了版面费。目前在等待清样了。这是我目前为止周期最快的一篇文章了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61f02159025, createdName=abbyabbyabby, createdTime=Fri Jan 07 09:56:22 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053521, encodeId=5b0f1053521db, content=糟糕透顶别投快跑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d055501799, createdName=ms6000000301719206, createdTime=Tue Sep 21 16:19:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1084036, encodeId=b3d61084036c2, content=杂志还算比较友好，但是发文速度非常慢，3月份投稿，一直找不到审稿人，期间推荐了三次审稿人，都没得消息，最后4个月才找到审稿人，又是漫长的等待。最后还好接受了，真的太漫长，前后加起来差不多10个月。着急毕业的建议不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lZCviaxzMSO1NPueY33sTwrlpzHGaNcwl2E5eYcDkPk97AfflLVSNZ8aFkXLBqRUT7QxFRQXRZKSlSctwT0eBrg/132, createdBy=82565232753, createdName=kk个, createdTime=Fri Dec 24 21:20:26 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2021-09-21 ms6000000301719206

糟糕透顶别投快跑

163 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209895, encodeId=944f12098952a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2022-2-9 投稿 2022-3-4 两个审稿人，均为大修；交互界面打开 2022-3-24 两个审稿人，endorsed 2033-3-31 accepted 为了毕业投的，还好，审稿时间较快，目前接收的最快的一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=710a2027187, createdName=小木公, createdTime=Sat Apr 09 21:31:25 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003160, encodeId=c1c410031608f, content=26 Jul 2021 Article accepted for publication. Review of Review Editor 2 finalized. Corresponding Author re-submitted manuscript. 15 Jul 2021 Review of Review Editor 1 finalized. 14 Jul 2021 Corresponding Author re-submitted manuscript. 08 Jul 2021 Interactive review forum activated. 07 Jun 2021 Corresponding Author submitted manuscript. 2个大修版面费贵 <a href='/topic/show?id=14d4259120b' target=_blank style='color:#2F92EE;'>#传染病#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=10, topicName=null, topicId=null, topicList=[TopicDto(id=25912, encryptionId=14d4259120b, topicName=传染病)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Tue Jul 27 22:51:33 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1215262, encodeId=889912152622b, content=21提交，22号要求提供原始数据，22晚上提交原始数据，至今快一周了，初步审查还没结束，各位initial validation多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=Uro_Hu, createdTime=Thu Apr 28 10:50:21 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223998, encodeId=1ad012239984e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康;糖尿病 经验分享：3.24 投稿 5.11 独立审稿开始 5.17 审稿报告1提交,微修 5.23 审稿报告2提交，微修 5.26 交叉评审激活 5.27 返修 5.31 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210819/e4601e63935540b094f6dcf2255c699c/bf4f523e8d894500a5e99cc898b63e92.jpg, createdBy=b7fb5436174, createdName=ms5000001545848377, createdTime=Thu Jun 02 09:58:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220564, encodeId=031512205643b, content=审稿速度:1.0 偏重的研究方向：近视;心理 经验分享：本人第一次写SCI，4月22日投稿，5.17第一个审稿人意见修回，改语法和图表格式，其他没意见，开心，期待下一个审稿人建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85145130725, createdName=146561f5m66暂无昵称, createdTime=Tue May 17 23:03:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181761, encodeId=da511181e6185, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2950.0 偏重的研究方向：公共卫生;糖尿病 经验分享：2021年11月底投稿，编辑很快就处理了，并让我邮件他推荐审稿人，我就随便巴拉了几个不认识的审稿人，12月中旬返回一个审稿意见是小修并且直接同意发表，就关了互动模块了，12月23号又返回了一个修稿意见认为应该换一个统计方法，两天就返回去修稿意见了，12月底就接受了，1月初交了版面费。目前在等待清样了。这是我目前为止周期最快的一篇文章了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61f02159025, createdName=abbyabbyabby, createdTime=Fri Jan 07 09:56:22 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053521, encodeId=5b0f1053521db, content=糟糕透顶别投快跑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d055501799, createdName=ms6000000301719206, createdTime=Tue Sep 21 16:19:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1084036, encodeId=b3d61084036c2, content=杂志还算比较友好，但是发文速度非常慢，3月份投稿，一直找不到审稿人，期间推荐了三次审稿人，都没得消息，最后4个月才找到审稿人，又是漫长的等待。最后还好接受了，真的太漫长，前后加起来差不多10个月。着急毕业的建议不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lZCviaxzMSO1NPueY33sTwrlpzHGaNcwl2E5eYcDkPk97AfflLVSNZ8aFkXLBqRUT7QxFRQXRZKSlSctwT0eBrg/132, createdBy=82565232753, createdName=kk个, createdTime=Fri Dec 24 21:20:26 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2023-12-04 ms1000001829214282 来自重庆

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：心理
经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。

26 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209895, encodeId=944f12098952a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：2022-2-9 投稿 2022-3-4 两个审稿人，均为大修；交互界面打开 2022-3-24 两个审稿人，endorsed 2033-3-31 accepted 为了毕业投的，还好，审稿时间较快，目前接收的最快的一篇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=710a2027187, createdName=小木公, createdTime=Sat Apr 09 21:31:25 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003160, encodeId=c1c410031608f, content=26 Jul 2021 Article accepted for publication. Review of Review Editor 2 finalized. Corresponding Author re-submitted manuscript. 15 Jul 2021 Review of Review Editor 1 finalized. 14 Jul 2021 Corresponding Author re-submitted manuscript. 08 Jul 2021 Interactive review forum activated. 07 Jun 2021 Corresponding Author submitted manuscript. 2个大修版面费贵 <a href='/topic/show?id=14d4259120b' target=_blank style='color:#2F92EE;'>#传染病#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=10, topicName=null, topicId=null, topicList=[TopicDto(id=25912, encryptionId=14d4259120b, topicName=传染病)], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/09/90c43e208f90c98f3386f19b2dc3d3b7.jpg, createdBy=a1962178299, createdName=爱爬树的松鼠, createdTime=Tue Jul 27 22:51:33 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155981, encodeId=6fe6215598155, content=偏重的研究方向：高血压;公共卫生 经验分享：8月26日投完，今天看了下在第三步分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epSeSRnibHGghiaoiciasFPibH4rTcIEDFbW29H2h6ia4pcUJNScVlysCgiamcgZeTadfxTwFeMQSDM88Cuw/132, createdBy=11d31990792, createdName=膨胀的指挥官, createdTime=Mon Sep 04 09:06:23 CST 2023, time=2023-09-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1215262, encodeId=889912152622b, content=21提交，22号要求提供原始数据，22晚上提交原始数据，至今快一周了，初步审查还没结束，各位initial validation多长时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220312/a6ec610c1be94b2b9c2759cc7dbcec9f/fa19af5a87c04a6e8693ba1e10cd3109.jpg, createdBy=92925410539, createdName=Uro_Hu, createdTime=Thu Apr 28 10:50:21 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223998, encodeId=1ad012239984e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：公共健康;糖尿病 经验分享：3.24 投稿 5.11 独立审稿开始 5.17 审稿报告1提交,微修 5.23 审稿报告2提交，微修 5.26 交叉评审激活 5.27 返修 5.31 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210819/e4601e63935540b094f6dcf2255c699c/bf4f523e8d894500a5e99cc898b63e92.jpg, createdBy=b7fb5436174, createdName=ms5000001545848377, createdTime=Thu Jun 02 09:58:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220564, encodeId=031512205643b, content=审稿速度:1.0 偏重的研究方向：近视;心理 经验分享：本人第一次写SCI，4月22日投稿，5.17第一个审稿人意见修回，改语法和图表格式，其他没意见，开心，期待下一个审稿人建议。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85145130725, createdName=146561f5m66暂无昵称, createdTime=Tue May 17 23:03:29 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181761, encodeId=da511181e6185, content=审稿速度:1.0 | 投稿命中率:95.0 | 版面费用:2950.0 偏重的研究方向：公共卫生;糖尿病 经验分享：2021年11月底投稿，编辑很快就处理了，并让我邮件他推荐审稿人，我就随便巴拉了几个不认识的审稿人，12月中旬返回一个审稿意见是小修并且直接同意发表，就关了互动模块了，12月23号又返回了一个修稿意见认为应该换一个统计方法，两天就返回去修稿意见了，12月底就接受了，1月初交了版面费。目前在等待清样了。这是我目前为止周期最快的一篇文章了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61f02159025, createdName=abbyabbyabby, createdTime=Fri Jan 07 09:56:22 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053521, encodeId=5b0f1053521db, content=糟糕透顶别投快跑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3d055501799, createdName=ms6000000301719206, createdTime=Tue Sep 21 16:19:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172831, encodeId=136d21e283167, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理 经验分享：2023.7.26提交 7.29分配编辑 8.2review 10.22返回两个审稿意见，都是大修 10.25返回修改 10.27审稿人一个同意发表，一个拒绝发表 10.31向编辑申诉和解释，向审稿人再次解释（期间一个月文章状态停留在互评那一步） 11.26编辑添加审稿人3，审稿人3意见小修 11.27返回修改意见 11.28审稿人3同意发表，编辑当天接收！真的是一言难尽，有的审稿人就是鸡蛋里挑骨头，有时机会要自己争取，希望我的经历可以帮到大家。ps:我同时还投了另外一篇，另一篇直接秒拒。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61be8573025, createdName=ms1000001829214282, createdTime=Mon Dec 04 11:50:21 CST 2023, time=2023-12-04, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1084036, encodeId=b3d61084036c2, content=杂志还算比较友好，但是发文速度非常慢，3月份投稿，一直找不到审稿人，期间推荐了三次审稿人，都没得消息，最后4个月才找到审稿人，又是漫长的等待。最后还好接受了，真的太漫长，前后加起来差不多10个月。着急毕业的建议不要投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lZCviaxzMSO1NPueY33sTwrlpzHGaNcwl2E5eYcDkPk97AfflLVSNZ8aFkXLBqRUT7QxFRQXRZKSlSctwT0eBrg/132, createdBy=82565232753, createdName=kk个, createdTime=Fri Dec 24 21:20:26 CST 2021, time=2021-12-24, status=1, ipAttribution=)]

2021-12-24 kk个

杂志还算比较友好，但是发文速度非常慢，3月份投稿，一直找不到审稿人，期间推荐了三次审稿人，都没得消息，最后4个月才找到审稿人，又是漫长的等待。最后还好接受了，真的太漫长，前后加起来差不多10个月。着急毕业的建议不要投

124 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务